4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-23-008356
Options or other derivatives
- Chief Financial Officer acquired 197,472 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Levine James E. Chief Financial Officer | 2023-03-15 | Grant or award · Stock Options | +197,472 | 757,488 | D | ||
Loading xslF345X03/wf-form4_167900291678685.xml…